Pomdoctor Limited to End ADR Program and Move Class A Shares to Nasdaq in 10-for-1 Consolidation
Pomdoctor Limited is ending its American Depositary Receipt program prior to the market open on October 21, 2026. Moving forward, the company will list its Class A ordinary shares directly on the Nasdaq stock market.
As part of the structural transition, the company is executing a 10-for-1 share consolidation. Under the terms of the conversion, holders of American Depositary Shares will undergo a mandatory exchange where every 10 American Depositary Shares become three post-consolidation Class A ordinary shares.
This change reorganizes the equity structure to trade directly as ordinary shares rather than depositary receipts. Investors should watch for potential short-term price adjustments and changes in trading liquidity when the shares begin trading under the new setup on Nasdaq on October 21.
Key points
- Pomdoctor Limited will terminate its American Depositary Receipt program before market open on October 21, 2026.
- The company will list Class A ordinary shares directly on Nasdaq starting October 21, 2026.
- A 10-for-1 share consolidation will automatically convert every 10 American Depositary Shares into 3 post-consolidation Class A shares.
Written by our AI from expert market sources across the web. It can contain mistakes: check the facts before acting on them. Write-ups powered by the free AI API at FreeTheAI.org
How we writeDisclaimerQuestions and answers
When will Pomdoctor Limited end its ADR program?
Pomdoctor Limited will terminate its ADR program before the market opens on October 21, 2026.
How will Pomdoctor Limited shares convert from ADSs?
Under the 10-for-1 share consolidation, every 10 American Depositary Shares will mandatorily convert into 3 post-consolidation Class A ordinary shares.
Where will Pomdoctor Limited shares trade after October 21, 2026?
Pomdoctor Limited will list its Class A ordinary shares directly on Nasdaq starting October 21, 2026.